Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative ...

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited ...

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down ...

Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to ...

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.